Skip to main content
. 2016 Jan 1;242(9):986–995. doi: 10.1177/1535370216684041

Table 2.

Postischemic metabolic parameters

Tw = 0 min Tw = 30 min Tw = 60 min Tw = 90 min Tw = 120 min
MVO2 (mL/min/g) Control 1.3 ± 0.2 1.5 ± 0.2* 1.6 ± 0.3* 1.7 ± 0.3* 1.5 ± 0.3
 Deltorphin D 1.2 ± 0.2 1.7 ± 0.1* 1.8 ± 0.1* 1.6 ± 0.1* 1.4 ± 0.2
 Cariporide 1.4 ± 0.1 2.0 ± 0.2* 2.1 ± 0.4* 2.1 ± 0.2* 1.8 ± 0.2
Lactate µg/min/g) Control 59 ± 8 59 ± 10 44 ± 11 44 ± 17 25 ± 13*
 Deltorphin D 57 ± 14 39 ± 9 † 24 ± 10* 15 ± 10* 27 ± 18*
 Cariporide 80 ± 10 89 ± 21 56 ± 19 31 ± 7* 20 ± 7*

All values are mean ± SE.

Cariporide: 3 µM included in the reperfusion buffer; Control: no reperfusion therapy; Deltorphin D: 1 µM Deltorphin D included in the reperfusion buffer; Tw = 0 min, working mode initiation (∼30 min postreperfusion and Deltorphin D administration); Lactate: lactate efflux across the heart (in µg/min per gram heart weight); MVO2: myocardial oxygen consumption (in mL O2/ min per gram heart weight).

*

P < 0.05 versus Tw = 0 min (repeated measures ANOVA); †P < 0.05 versus cariporide (ANOVA).